GSK3β and Plk1 sequentially phosphorylate ATP–citrate lyase to promote homologous recombination
Science Advances · 11.09.2026 · 12 (37)
DOI: 10.1126/sciadv.aeg1097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 11.09.2026. Verfasst von Shinan Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Hangzhou City University, Hangzhou, China. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Glycogen Synthase Kinase 3 beta, Cell Cycle Proteins, Proto-Oncogene Proteins. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, National key R&D program of China.
Abstract (Originalsprache)
Accurate repair of DNA double-strand breaks (DSBs) by homologous recombination (HR) is essential for genome stability. Nuclear production of acetyl–coenzyme A (acetyl-CoA) by ATP–citrate lyase (ACLY) promotes HR, yet how ACLY is regulated during the DNA damage response (DDR) remains unclear. Here, we identify a phosphorylation-dependent signaling axis in which glycogen synthase kinase 3β (GSK3β) and Polo-like kinase 1 (Plk1) act sequentially on ACLY to facilitate HR-mediated repair of DSBs induced by ionizing radiation. Following AKT-dependent phosphorylation of ACLY at Ser 455 , GSK3β phosphorylates ACLY at Thr 447 , generating a docking site for Plk1, which in turn phosphorylates ACLY at Ser 442 . This phosphorylation cascade, enhanced by radiation, sustains histone acetylation, supports the accumulation of BRCA1 and RAD51 at DSBs, and confers cellular resistance to poly(ADP-ribose) polymerase (PARP) inhibition. Together, our findings define an AKT-GSK3β-Plk1-ACLY signaling module that links the DDR to nuclear metabolism, revealing a critical mechanism by which kinase signaling facilitates acetyl-CoA–dependent chromatin remodeling to preserve genome integrity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine, Hangzhou City University, Hangzhou, China.
- Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- MOE Laboratory of Biosystems Homeostasis and Protection, Life Sciences Institute, Zhejiang University, Hangzhou, China.
- Zhejiang Key Laboratory of Geriatrics and Geriatrics Institute of Zhejiang Province, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China.
ORCID-Profile: Shinan Zhou, Xinyu Zhou, Qinfu Chen, Xueying Yuan, Shukai Zhu, Jun Huang, Fangwei Wang, Haiyan Yan
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- National key R&D program of China
- Natural Science Foundation of Zhejiang Province
- Central Guidance for Local Scientific and Technological Development Funding Project
Zitieren
APA
Zhou, S., Zhou, X., Chen, Q., Yuan, X., Zhu, S., Huang, J., Wang, F., & Yan, H. (2026). GSK3β and Plk1 sequentially phosphorylate ATP–citrate lyase to promote homologous recombination. Science Advances, 12(37). https://doi.org/10.1126/sciadv.aeg1097
Vancouver
Zhou S, Zhou X, Chen Q, Yuan X, Zhu S, Huang J, et al. GSK3β and Plk1 sequentially phosphorylate ATP–citrate lyase to promote homologous recombination. Science Advances. 2026;12(37). doi:10.1126/sciadv.aeg1097
BibTeX
@article{Zhou2026,
author = {Zhou, Shinan and Zhou, Xinyu and Chen, Qinfu and Yuan, Xueying and Zhu, Shukai and Huang, Jun and Wang, Fangwei and Yan, Haiyan},
title = {GSK3β and Plk1 sequentially phosphorylate ATP–citrate lyase to promote homologous recombination},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {37},
doi = {10.1126/sciadv.aeg1097}
}
EUVIMED